Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer

American Journal of Pathology

Volumn 178, Issue 4, 2011, Pages 1461-1469

  Chambon, Monique ^a,b   Orsetti, Béatrice ^a,b   Berthe, Marie Laurence ^c   Bascoul Mollevi, Caroline ^d   Rodriguez, Carmen ^a,b   Duong, Vanessa ^a,b,e   Gleizes, Michel ^a,b   Thénot, Sandrine ^a,b,f   Bibeau, Frédéric ^g   Theillet, Charles ^a,b   Cavaillès, Vincent ^a,b  

^a INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^b UNIV MONTPELLIER   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

^d CENTRE VAL D AURELLE   (France)

^e INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^f UNIVERSITÉ DE LYON   (France)

^g Ecole Normale Supérieure de Lyon ^*

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL NUCLEUS RECEPTOR; MESSENGER RNA; POLYCLONAL ANTIBODY; POLYCLONAL ANTIBODY TS1; PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TRIM24; UNCLASSIFIED DRUG;

ARTICLE; BREAST; BREAST BIOPSY; BREAST CANCER; BREAST EPITHELIUM; BREAST TUMOR; CANCER GENETICS; CELL NUCLEUS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TRANSCRIPTION REGULATION;

EID: 79953660457     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.12.026     Document Type: Article

References (32)

1. Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat P, Heery D, Gronemeyer H, Chambon P, Losson R: The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995, 14:2020-2033
2. Thenot S, Henriquet C, Rochefort H, Cavailles V: Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1. J Biol Chem 1997, 272:12062-12068 (Pubitemid 27202785)
3. Le Douarin B, Nielsen AL, Garnier JM, Ichinose H, Jeanmougin F, Losson R, Chambon P: A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J 1996, 15:6701-6715 (Pubitemid 26413802)
4. Le Douarin B, You J, Nielsen AL, Chambon P, Losson R: TIF1alpha: a possible link between KRAB zinc finger proteins and nuclear receptors. J Steroid Biochem Mol Biol 1998, 65:43-50 (Pubitemid 28335589)
5. Teyssier C, Ou CY, Khetchoumian K, Losson R, Stallcup MR: Transcriptional intermediary factor 1 alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivators. Mol Endocrinol 2006, 20:1276-1286 (Pubitemid 43801230)
6. Haynes SR, Dollard C, Winston F, Beck S, Trowsdale J, Dawid IB: The bromodomain: a conserved sequence found in human. Drosophila and yeast proteins. Nucleic Acids Res 1992, 20:2603
7. Reddy BA, Etkin LD, Freemont PS: A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem Sci 1992, 17:344-345
8. Nielsen AL, Ortiz JA, You J, Oulad-Abdelghani M, Khechumian R, Gansmuller A, Chambon P, Losson R: Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family. EMBO J 1999, 18:6385-6395 (Pubitemid 29533242)
9. Fraser RA, Heard DJ, Adam S, Lavigne AC, Le Douarin B, Tora L, Losson R, Rochette-Egly C, Chambon P: The putative cofactor TIF1alpha is a protein kinase that is hyperphosphorylated upon interaction with liganded nuclear receptors. J Biol Chem 1998, 273: 16199-16204 (Pubitemid 28311393)
10. Allton K, Jain AK, Herz HM, Tsai WW, Jung SY, Qin J, Bergmann A, Johnson RL, Barton MC: Trim24 targets endogenous p53 for degradation. Proc Natl Acad Sci USA 2009, 106:11612-11616
11. Remboutsika E, Lutz Y, Gansmuller A, Vonesch JL, Losson R, Chambon P: The putative nuclear receptor mediator TIF1alpha is tightly associated with euchromatin. J Cell Sci 1999, 112:1671-1683 (Pubitemid 29295044)
12. Niederreither K, Remboutsika E, Gansmuller A, Losson R, Dollé P: Expression of the transcriptional intermediary factor TIF1alpha during mouse development and in the reproductive organs. Mech Dev 1999, 88:111-117 (Pubitemid 29467418)
13. LeDouarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat P, Heery D, Gronemeyer H, Chambon P, Losson R: The N-terminal part of TIF1, a putative mediator of the ligand- dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995, 14:2020-2033
14. Zhong S, Delva L, Rachez C, Cenciarelli C, Gandini D, Zhang H, Kalantry S, Freedman LP, Pandolfi PP: A RA-dependent, tumourgrowth suppressive transcription complex is the target of the PMLRARalpha and T18 oncoproteins. Nat Genet 1999, 23:287-295 (Pubitemid 29526425)
15. Klugbauer S, Rabes HM: The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 1999, 18:4388-4393 (Pubitemid 29392380)
16. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van't Veer LJ, Perou CM: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 2006, 355:560-569 (Pubitemid 44200649)
17. Bertucci F, Orsetti B, Negre V, Finetti P, Rouge C, Ahomadegbe JC, Bibeau F, Mathieu MC, Treilleux I, Jacquemier J, Ursule L, Martinec A, Wang Q, Benard J, Puisieux A, Birnbaum D, Theillet C: Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene 2008, 27:5359-5372
18. Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Rouge C, Ursule L, Nguyen C, Bibeau F, Rodriguez C, Theillet C: Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Br J Cancer 2006, 95:1439-1447 (Pubitemid 44760099)
19. Soule HD, Vazguez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973, 51:1409-1416
20. Perou CM, Sorlie T, Eisen MB, van de RM, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature 2000, 406:747-752
21. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van d V, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347:1999-2009
22. 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der KK, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536
23. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sorlie T, Dai H, He YD, van'T Veer LJ, Bartelink H, van de RM, Brown PO, van de Vijver MJ: Robustness, scalability, and integration of a woundresponse gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 2005, 102:3738-3743 (Pubitemid 40354681)
24. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004, 351:2817-2826
25. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, Muir B, Mohapatra G, Salunga R, Tuggle JT, Tran Y, Tran D, Tassin A, Amon P, Wang W, Wang W, Enright E, Stecker K, Estepa-Sabal E, Smith B, Younger J, Balis U, Michaelson J, Bhan A, Habin K, Baer TM, Brugge J, Haber DA, Erlander MG, Sgroi DC: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004, 5:607-616 (Pubitemid 38748922)
26. Khetchoumian K, Teletin M, Tisserand J, Herquel B, Ouararhni K, Losson R: Trim24 (Tif1 alpha): an essential 'brake' for retinoic acid-induced transcription to prevent liver cancer. Cell Cycle 2008, 7:3647-3652
27. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM: ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004, 6:1-6 (Pubitemid 38391943)
28. Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, Liao X, Iglehart JD, Livingston DM, Ganesan S: X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006, 9:121-132 (Pubitemid 43202662)
29. Gandini D, De Angeli C, Aguiari G, Manzati E, Lanza F, Pandolfi PP, Cuneo A, Castoldi GL, del Senno L: Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML. Leukemia 2002, 16:886-893 (Pubitemid 34537562)
30. Popanda O, Zheng C, Magdeburg JR, Buttner J, Flohr T, Hagmuller E, Thielmann HW: Mutation analysis of replicative genes encoding the large subunits of DNA polymerase alpha and replication factors A and C in human sporadic colorectal cancers. Int J Cancer 2000, 86:318-324 (Pubitemid 30187490)
31. Strefford JC, Stasevich I, Lane TM, Lu YJ, Oliver T, Young BD: A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma. Cancer Genet Cytogenet 2005, 159:1-9 (Pubitemid 40614716)
32. Jain AK, Barton MC: Regulation of p53: tRIM24 enters the RING. Cell Cycle 2009, 8:3668-3674